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Abstract
Cell fate decisions depend on the interplay between chromatin regulators and transcription factors.
Here we show that activity of the Mi-2β nucleosome remodeling and deacetylase (NuRD) complex
was controlled by the Ikaros family of lymphoid-lineage determining proteins. Ikaros, an integral
component of the NuRD complex in lymphocytes, tethered this complex to active lymphoid
differentiation genes. Loss in Ikaros DNA binding activity caused a local increase in Mi-2β
chromatin remodeling and histone deacetylation and suppression of lymphoid gene expression.
The NuRD complex also redistributed to transcriptionally poised non-Ikaros gene targets,
involved in proliferation and metabolism, inducing their reactivation. Thus, release of NuRD from
Ikaros regulation blocks lymphocyte maturation and mediates progression to a leukemic state by
engaging functionally opposing epigenetic and genetic networks.
Introduction
The fate of a cell is determined by the way that its genetic material and its protein scaffold,
collectively referred to as chromatin, are modified. Chromatin influences the outcome of
DNA-based processes such as transcription, replication, recombination and repair. The
structure of chromatin is in part modulated by functionally diverse enzymes, which modify
histones in the basic chromatin unit, the nucleosome, thereby providing direct or indirect
modes of regulation of DNA accessibility. Histone acetylation can directly influence
nucleosome configuration and is supportive of transcription initiation and elongation1,2.
Histone acetyltransferases (HATs) and deacetylases (HDACs) were recently shown to be
concomitantly loaded on active genes possibly in anticipation of transcriptional changes3.
The Mi-2β nucleosome remodeling and histone deacetylase complex (NuRD) is one of
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several histone deacetylase complexes present in mammalian cells but is unique in that it
contains both chromatin opening and closing enzymatic activities4,5. It has been
hypothesized that the ATP-dependent nucleosome remodeling activity of Mi-2β enables
activity of the associated HDACs in the NuRD complex4. Chromatin modifying and
remodeling activities are thought to be recruited to specific loci through association with
sequence-specific DNA-binding factors, direct binding to pre-existing histone modifications,
or other mechanisms6. In cells of the hematopoietic lineage, the NuRD complex stably
associates with the Ikaros family of lymphoid lineage-determining DNA binding factors7,8.
Thus the association between the NuRD complex and Ikaros proteins provides a unique
paradigm by which to delineate how chromatin regulation is harnessed for the benefit of key
developmental transitions.
The Ikaros gene family encodes zinc finger DNA binding proteins that serve as key
regulators of lymphocyte development, function and homeostasis9. Ikaros primes the
lymphoid lineage potential of multipotent progenitors and its loss severs lymphoid lineage
specification and commitment10,11. After commitment into the T cell lineage, a higher level
of Ikaros activity is required for homeostasis of differentiating precursors. Thymocytes, past
the double-negative (DN) stage of differentiation, express high amounts of both the Ikaros
and Aiolos family members12, and are exquisitely sensitive to perturbations in Ikaros DNA
binding activity. Reduction in Ikaros that is not sufficient to interfere with early lymphoid
lineage decisions nevertheless causes aberrant expansion of CD4+CD8+ (DP) TCRint
thymocytes, which are reminiscent of cells undergoing TCR-mediated selection13,14. Ikaros-
deficient DP TCR+ thymocytes, in response to a series of triggers including activation of
Notch signaling, undergo further transition to a leukemic state15,16.
Genetic studies on Ikaros and Mi-2β have independently established their participation
within the same molecular processes but have also uncovered an unexpected functional
antagonism17,18. In multipotent hematopoietic progenitors, Ikaros promotes lymphoid
lineage priming and commitment, whereas Mi-2β inhibits this process11 (T. Y. unpublished
data). Loss of Ikaros results in illegitimate Cd4 activation in DN thymocytes, whereas loss
of Mi-2β results in illegitimate Cd4 silencing in DP thymocytes18. Similarly, loss of Ikaros
causes aberrant T cell activation whereas loss of Mi-2β interferes with T cell activation and
proliferation17,19. Ikaros mutant mice develop T cell leukemia whereas Ikaros and Mi-2β
doubly deficient mice survive past 6 months and are disease free (unpublished data). In spite
of its critical role in lymphocyte development and leukemogenesis, the molecular basis of
Ikaros and Mi-2β antagonism remains elusive.
Using this genetic system we show that in DP thymocytes, the NuRD complex contained
both Ikaros and Aiolos and was targeted predominantly through common DNA binding
motifs to transcriptionally active lymphoid differentiation genes. Loss in Ikaros correlated
with a local gain in NuRD function, which was still recruited to these sites through Aiolos.
Increased nucleosome remodeling and histone deactylase activity were detected that
interfered with RNA polymerase II (RNA polII) recruitment and lymphoid gene expression.
In addition, loss of Ikaros from the NuRD complex resulted in NuRD redistribution to
permissive chromatin of transcriptionally poised, non-Ikaros gene targets, involved in cell
growth and metabolism, causing their reactivation. We thus propose that balanced targeting
of the NuRD complex through lineage-specific DNA binding factors and chromatin code is
key to the timely induction of differentiation versus growth and proliferation genetic
programs during development. Deregulation of this process causes differentiation arrest and
leukemic transformation.
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RESULTS
NuRD complex composition in primary DP thymocytes
Association between the NuRD complex and Ikaros proteins was previously reported in
cycling T cells and erythroleukemia cells7,8. We investigated whether this interaction also
occurs in DP thymocytes which comprise 85% of the primary thymocyte population. DP
thymocytes are quiescent cells that express abundant Ikaros family proteins and which need
to undergo T cell receptor (TCR) recombination and selection prior to differentiating into
immunocompetent T cells20.
Two protein complexes were purified from primary thymocytes using either an epitope-
tagged Mi-2β or Ikaros protein, expressed in transgenic mice (Fig. 1a). Mi-2β is an ATP-
dependent nucleosome remodeler and an essential and non-redundant component of the
NuRD complex that binds directly, and with high affinity, to Ikaros proteins21. Ikaros, its
family member Aiolos, and NuRD complex components such as MTA1, 2, HDAC1, 2, and
Rbp46, 48 were identified by protein microsequencing (Fig. 1). Immunoblot analysis
verified strong enrichment of NuRD components in both complexes, relative to
unfractionated nuclear extract (Fig. 1b and Supplementary Table 1). This result is
consistent with previous Ikaros-based complex purifications from actively cycling T cells
(Fig. 1a, cy-T cells)7. Thus, Ikaros DNA binding proteins are stable components of the
NuRD complex in quiescent DP thymocytes as in cycling T cells.
Genome-wide targeting of the Ikaros-NuRD complex
Ikaros’ DNA binding activity is required for lymphocyte development and homeostasis and
its ability to target chromatin remodeling in a sequence-specific manner has been proposed
as its modus operandi in the NuRD complex9. To test this hypothesis, the genome-wide
distribution of Ikaros and Mi-2β was established in DP thymocytes by chromatin
immunoprecipitations and DNA sequencing (ChIP-Seq). Ikaros bound to 7120 sites whereas
Mi-2β bound to 4158 sites (P-value <10−5), which associated respectively with 4675 and
3156 gene targets (Fig. 2a and Table 1). Approximately 53% of Mi-2β binding sites and
~36% of Ikaros binding sites were associated with each other at the gene level, as identified
by the closest transcription start site (Fig. 2a, P-value < 10−320). Ward hierarchical
clustering centered on either Ikaros or Mi-2β enrichment peaks verified this proximity (Fig.
2b and Supplementary Fig. 1a, b). Ikaros and Mi-2β were similarly distributed at six
different genomic locations with intergenic (40% vs. 36%) and promoter-proximal (42% vs.
47%) being the most prevalent (Fig. 2c). Taken together, protein complex purification and
mapping studies confirm that Ikaros works through the NuRD complex at distinct regulatory
regions of the DP genome.
Ikaros-NURD complex targets permissive chromatin
We next examined the chromatin environment surrounding Ikaros and Mi-2β sites and the
transcriptional state of their gene targets. Ward hierarchical clustering22 centered on Ikaros
sites at promoter proximal locations (3 kb upstream or downstream of TSS) revealed
extensive association with permissive histone H3 modifications (methylation of lysine 4
(H3K4me3, 2, 1) or acetylation of lysine 9, H3K9Ac) as well as with RNA polII (Fig. 2b
and Table 1). A similar association was observed at promoter-distal (greater than 3 kb of
TSS) Ikaros sites, which depending on H3K4me1, me2 and me3 distributions could be
further classified into strong or weak and or poised enhancers (Fig. 2b)23. In contrast, there
was little direct overlap between Ikaros or Mi-2β sites and H3 trimethylated lysine 27
(H3K27me3), a mark of PRC2 polycomb complex activity and silent or bivalent
chromatin24,25. Nonetheless, Ikaros or Mi-2β sites and H3K27me3 sites although non-
overlapping were frequently (40%) associated at the gene level (Table 1).
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RNA expression analysis in DP thymocytes indicated that Ikaros and Mi-2β gene targets
were transcriptionally more active compared to genes not bound by these factors (Fig. 2d).
Approximately 70% of Ikaros and Mi-2β gene targets were enriched for the H3K36me3
transcription elongation mark (Table 1). Since ~25% of Ikaros and Mi-2β sites were in close
proximity to promoters we examined their distribution relative to the transcription start site
(TSS) (Fig. 2e). Ikaros distribution was centered on the TSS, fitting within the groove
generated by the H3K4me3 and H3K9Ac-K14Ac marked nucleosomes that flank a
transcriptionally active TSS. RNA polII distribution overlapped that of Ikaros. Interestingly,
Mi-2β exhibited a broader distribution over the TSS, covering Ikaros, the two TSS-flanking
nucleosomes and RNA polII. Thus in DP thymocytes, Ikaros and Mi-2β predominantly
associate with transcriptionally active genes, frequently in the immediate vicinity of the
RNA polII complex, implicating a direct role in the transcription cycle.
Ikaros loss and gain in NuRD chromatin enrichment
The role of Ikaros in targeting the NuRD complex was evaluated by comparing Mi-2β
distribution in wild-type and Ikaros null pre-leukemic thymocytes obtained from 3-5 week
old mice. As in wild-type cells, a large proportion of Ikaros null thymocytes were found at
the DP stage and had not activated Notch signaling, which is a late event in leukemic
progression16,18. An unexpected enrichment in Mi-2β binding was observed in Ikaros null
chromatin (Fig. 3a,b). This result was not due to higher Mi-2β mRNA or protein abundance
(Fig. 3c and Supplementary Fig. 2). It was also not due to a global effect on chromatin
accessibility, as binding of RNA polII and other factors in the vicinity of Mi-2β sites was not
increased (Fig. 3a, e), suggesting a specific effect on Mi-2β chromatin access. Different
methods of analysis with comparable normalized reads from Mi-2β ChIP-Seq in wild-type
and Ikaros null thymocytes consistently showed increased Mi-2β enrichment
(Supplementary Fig. 1c and Fig. 3a). A <2 fold increase in Mi-2β binding was seen at sites
normally bound by Ikaros in wild-type (Fig. 3a,b), the majority of which were also occupied
by Aiolos, the second-most prevalent Ikaros family member and NuRD complex component
in thymocytes (Fig. 3a and Fig. 1). However, a greater (>3.5 fold) increase was detected at
non-Ikaros sites and gene targets (Fig. 3a, b).
The vast majority of de novo and pre-existing Mi-2β sites detected in Ikaros null chromatin
were in permissive chromatin, marked by H3K4me3, H3K9Ac and RNA polII, with a small
subset again associated with H3K27me3 (Fig. 3a and Table 1). Notably, the broad binding
pattern of Mi-2β observed in wild-type cells became progressively narrower in Ikaros null
chromatin (Fig. 3a,d) in a manner that inversely correlated with the presence of Ikaros-type
proteins in this complex. Thus although an increased number of chromatin sites are occupied
by Mi-2β in the absence of Ikaros-family proteins the binding pattern is more focused.
Overall the data suggest a gain in NuRD complex chromatin accessibility upon loss of
Ikaros.
NuRD complex activity is negatively regulated by Ikaros
We further evaluated the histone modification status in proximity to Mi-2β sites in Ikaros
null compared to wild-type chromatin. Ward hierarchical clustering of Mi-2β sites in Ikaros
null chromatin revealed an extensive decrease in histone acetylation in its immediate
vicinity detected with independent chromatin samples prepared from Ikaros null pre-
leukemic DP thymocytes (Fig. 3a). Cumulative distribution analysis centered on Mi-2β sites
confirmed the profound decrease in H3K9Ac-K14Ac frequency. In fact, the majority of
genome-wide loss in H3K9Ac-K14Ac marks (67%) in Ikaros null chromatin was directly
associated with Mi-2β occupancy (Supplementary Table 2). This analysis also revealed
increased nucleosome remodeling in the vicinity of Mi-2β sites in the null compared to wild-
type chromatin (Fig. 3e, K4me3 and K9Ac). Interestingly, an ablation of H3K27me3 was
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also detected at the subset of Mi-2β sites marked by this modification in wild-type chromatin
(Fig. 3a,e, K27me3), implicating a potential antagonism between Mi-2β–NuRD and the
PRC2 complex. In sharp contrast to the profound H3K9Ac decrease, the overall changes in
H3K4me3 and RNA polII were relatively small (Fig. 3a,e). Nonetheless, the majority of the
RNA polII changes were associated with increased Mi-2β occupancy (Supplementary
Table 2).
The effect of Ikaros DNA binding on the nucleosome remodeling activity of Mi-2β was
further investigated in vitro (Supplementary Fig. 3). Mononucleosomes and 5S
nucleosomal arrays were generated with DNA templates containing rotational phasing
sequences and Ikaros consensus sites. As a negative control, DNA template with non-
binding Ikaros site mutations was used for mononucleosome assembly. The Ikaros-Mi-2β
complex bound with specificity to both naked DNA and mononucleosomes harboring Ikaros
binding sites but not to DNA or mononucleosomes without Ikaros sites (Supplementary
Fig. 3a,b). Notably, binding of the Ikaros-NuRD complex to mononucleosomes was
stimulated by ATP. Ikaros-specific DNA binding was validated by incubation with an Ikaros
antibody that decreased the mobility of the Ikaros-DNA binding complex (Supplementary
Fig. 3a, labeled αIk). DNA templates with and without Ikaros sites formed positioned
mononucleosomes as evidenced by the 10-bp repeat generated by the limited DNAse I
cleavage at DNA sites facing away from the histone octamer (Supplementary Fig. 3c). At
high concentrations of the Ikaros complex, an ATP-dependent disruption of the DNAse I
cleavage pattern was evidenced by characteristic enhancements and protections on both
templates, referred to as mononucleosome remodeling. However, at lower Ikaros complex
concentration remodeling occurred preferentially on nucleosomes without Ikaros sites.
Similarly, competition with oligonucleotides containing Ikaros binding sites provided more
Ikaros complex remodeling and restriction enzyme accessibility in 5S nucleosomal arrays
(Supplementary Fig. 3d). No such effect was observed with the hSWI-SNF nucleosome
remodeling complex purified from HeLa cells that does not contain Ikaros.
Taken together both in vivo and in vitro studies provide strong evidence that Ikaros DNA
binding plays an inhibitory role on Mi-2β chromatin accessibility and nucleosome
remodeling. Sequence-specific binding of the Ikaros-NuRD complex on nucleosomes likely
restricts access of Mi-2β to its nucleosomal substrate either through hindrance or by
interference with the activity of the remodeler. Inhibition of Ikaros sequence-specific DNA
binding stimulates Mi-2β nucleosome remodeling, which facilitates histone access and
deacetylation. Increases in nucleosome remodeling may also influence access or activity of
other chromatin modifiers such as the PRC2 complex, when recruited in proximity to the
NuRD complex.
Sequence specific targeting of the Ikaros-NURD complex
The DNA sequence specificity in the vicinity of Ikaros and Mi-2β binding sites was
investigated. Homer de novo motif analysis was performed first in the vicinity of Ikaros sites
at promoter-proximal and promoter-distal locations established in wild-type chromatin. The
majority of these sites were still occupied by Aiolos and Mi-2β in Ikaros null chromatin
(Fig. 3a).
Ikaros DNA binding motifs (Ik m1-m5) previously established in vitro26,27 were highly
enriched in the vicinity of Ikaros peaks in wild-type chromatin and of Aiolos peaks in Ikaros
null chromatin (Fig. 4a,b), indicating that both proteins target the NuRD complex to
chromatin with similar sequence specificity. The most prevalent Ikaros motif (Ik m1, 5’-
ACAGGAAGT-3’) detected at both promoter proximal and distal locations is a variant of an
Ets1 motif present in lymphoid-specific regulatory elements28. Some Ikaros motifs (for
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example, Ik m4) at promoters displayed similarity to STAT binding sites, suggesting
interplay between Ikaros and the JAK-STAT pathway. At promoter-distal Ikaros sites, a
highly significant enrichment of E2A-HEB motifs was identified (Fig. 4a,b). Ikaros
association with E-box proteins was further investigated by examining the genome-wide
distribution of HEB in DP thymocytes. HEB is an E2A family member that heterodimerizes
with E2A and mediates common effects on gene expression and TCR selection required for
T cell differentiation29-31. A highly significant association between HEB and Ikaros was
detected at enhancer locations (Fig. 4c). E2A binding sites were recently shown to associate
with Ikaros-like Ets1 (Ik m1) and Runx1 motifs at transcriptional enhancers active in B cell
precursors32. A significant association between Ikaros sites and Runx motifs was also
observed here at T cell enhancers (Fig. 4a,b). Ikaros also acts through its cognate sites
located at promoters and in proximity to basal transcription elements such as GC boxes and
binding motifs for CREB and NRF1 (Fig. 4a,b). Motifs for the insulator protein CTCF were
also associated with Ikaros at promoter and enhancer locations, albeit at lower frequency
(Fig. 4a, b). Together these studies reveal a strong conservation between T and B cell
enhancers and a key role for the Ikaros-NuRD complex in regulating gene accessibility and
expression, acting in concert with other key lymphoid lineage-specific transcription
regulators.
Mode of NuRD targeting identifies distinct gene networks
Analysis of Mi-2β enrichment peaks present in the vicinity of Ikaros or Aiolos enrichment
peaks were significantly associated with motifs for Ikaros and its lymphoid factor associates
indicating direct recruitment through these DNA binding factors (Fig. 5a, Mi-2β+Ik or Aio,
Ikm1, E2A, E-box, Runx). In sharp contrast, Mi-2β enrichment peaks that were not in the
vicinity of Ikaros or Aiolos enrichment peaks, did not associate at any significant frequency
with Ikaros or other lymphoid factor motifs (Fig. 5a, Mi-2β-Ik or Aio, Ikm1, E2A, E-box,
Runx). However in both cases, Mi-2β sites were highly enriched for basal transcription
elements such as GC boxes at promoters as well as with CTCF motifs at both promoter
proximal and distal regions (Fig. 5a, Mi-2β+ or – Ik or Aio, GC, CTCF). Thus in the
presence of Ikaros, the NuRD complex is targeted primarily to lymphoid-specific regulatory
regions highly enriched for Ikaros, E2A and Runx binding sites, whereas in the absence of
Ikaros, targeting occurs either by pre-existing permissive chromatin codes such as
H3K4me3 or through components of the basal transcription machinery.
Pathway analysis of genes targeted by the Ikaros–Mi-2β–NuRD complex or by the Mi-2β–
NuRD complex alone has provided insight into the functional consequences of NuRD's
differential targeting in wild-type and Ikaros null chromatin. Genes associated with Mi-2β–
NuRD de novo sites in Ikaros null chromatin that lack Ikaros DNA binding motifs, exhibited
strong and specific enrichment in pathways involved in cell growth such as mRNA,
phospholipid metabolism, protein translation as well as insulin, Wnt, Notch and mTOR
signaling (Fig. 5b, Mi-2β-Ik or Aio GT and Supplementary Fig. 4). In contrast, lymphoid-
specific genes and pathways involved in T cell activation, differentiation, migration and
adhesion, were specifically targeted by the Ikaros–NuRD complex (Fig. 5b, Mi-2β+Ik or
Aio GT and Supplementary Fig. 4). Both NuRD complexes associated with transcription,
cell cycle, DNA damage, apoptosis and catabolic processes albeit at different frequencies
and with different gene targets (Fig. 5b and Supplementary Fig. 4). Taken together, these
findings indicate that Mi-2β targets two classes of genetic networks that are functionally
distinct. One that is normally regulated by Ikaros and supports lymphocyte differentiation,
and a second that is guided by permissive chromatin code or basal transcription mechanisms
and which supports cell growth and proliferation.
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NuRD's opposing effects on differentiation vs. growth
The transcriptional effects of Ikaros-loss and Mi-2β–NuRD gain-of-function were evaluated
in DP thymocytes. Changes in the transcriptional elongation marker H3K36me3 in pre-
leukemic Ikaros null thymocytes were compared to changes in RNA expression in DP
thymocytes undergoing leukemic progression (pre-leukemic stage I and II)16. A common
signature of up- or down-regulated genes (1760 and 2193, respectively) was defined by a
change in both H3K36me3 and RNA expression (Fig. 6a, plotted from most to least
changed). Importantly, this signature was progressively deregulated during leukemogenesis
with most genes directly associated with Mi-2β or the Ikaros family of proteins (Fig. 6a and
Supplementary Table 3).
Down-regulated genes displayed a strong reduction in H3K9Ac-K14Ac modification as well
as a reduction in RNA polII occupancy (Fig. 6a,b, Down) that was more profound in the
vicinity of Mi-2β or Ikaros, Aiolos sites (Supplementary Table 2 and Fig. 5c). Genes in the
up-regulated group were transcriptionally poised in wild-type chromatin with H3K4me3,
H3K9Ac marks and with low frequencies of RNA polII occupancy at the TSS and of the
H3K36me3 elongation mark in the gene body (Fig 6a, Up). An increase in RNA polII
occupancy was observed in the up-regulated genes in spite of a decrease in H3K9Ac-K14Ac
histone modification. Nonetheless, the decrease in H3K9Ac-K14Ac was lower to that seen
in down-regulated genes (Fig 6a, and Supplementary Fig. 5b). In about a third of the up-
regulated genes, H3K27me3 was present in wild-type and lost in the Ikaros null chromatin
(Fig. 6a, Up and Supplementary Figs. 5b, 6b and Supplementary Table 3). Notably,
genes with the most significant increase in expression were frequently marked by
H3K27me3 in wild-type chromatin (Fig. 6a, Up).
Analysis of gene ontologies associated with the up- and down-regulated gene subsets have
revealed a division of labor for the NuRD complex during T cell development
(Supplementary Fig. 6). Pathways associated with T cell differentiation, activation,
hematopoiesis, lymphoid and immune system development and highly enriched by the
Ikaros–Mi-2β–NuRD complex were down-regulated, whereas pathways supporting
metabolism, and frequently enriched by the (Ikaros-free) Mi-2β–NuRD complex, were
strongly up-regulated (Supplementary Fig. 6). Key T cell differentiation genes such as
Cd4, Cd8, Rag1 and Rag2, Il4ra, Ifngr1, Ccnd3, Bcl2l1, Fas, Socs1,Tox, Pten, Ptprf were
identified within the Ikaros–Mi-2β–NuRD down-regulated group. A significant fraction of
these genes were also directly associated with the E2A partner, HEB (Fig. 6c and
Supplementary Fig. 7). Genes supporting basic cellular pathways in metabolism, cell
growth, migration and proliferation, such as Nans, Nsun2, Rrn3, Alox5p, Adcy7, Insgfr1
and 2, Elovl6, Trib1, Ddr1, Vcl1, Dock1, Sdc1, Mmp14, Maged1, Ccnd1, Myc, Smo and
Smad1, were identified in the Mi-2β-NuRD up-regulated group (Supplementary Fig. 6 and
7).
Taken together these studies indicate that during T cell differentiation the NuRD complex
regulates a range of genetic programs associated with differentiation, proliferation and
growth by engaging functionally disparate mechanisms. However, the presence of Ikaros
DNA binding activity in the NuRD complex restricts its action to the lymphoid
differentiation programs and in the maintenance of gene expression. Loss of Ikaros
unleashes NuRD activity to the full range of these genetic programs thereby interfering with
normal differentiation and causing aberrant growth and proliferation (Supplementary Fig.
8).
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Discussion
Our studies provide first insight into a mechanism that divides the labor of chromatin
remodeling complexes between differentiation-specific and general cellular tasks such as
proliferation and growth. We show that targeting through lineage-specific DNA binding
factors positioned chromatin remodelers for regulation of genetic programs supporting
differentiation while preventing their participation in programs that oppose differentiation.
We also show that while tethered to lineage-specific genes, the activity of chromatin
remodeling complexes was controlled by the DNA binding activity of associated lineage-
specific factors, possibly serving as a barrier that limits their chromatin access. This
potentially poised functional state provides an explanation for the steady state association of
restrictive chromatin modifiers with transcriptionally active genes3.
In the chromatin of both wild-type and Ikaros null thymocytes, the NuRD complex was
targeted to permissive chromatin, marked predominantly by H3K4me3, generated by the
trithorax group of chromatin regulators33. The presence of Ikaros-type proteins in the NuRD
complex further restricts this targeting to permissive chromatin that contains binding sites
for Ikaros family proteins and the E-box and Runx family members, found frequently in
lymphoid-specific regulatory elements. Here, the chromatin remodeling and histone
deacetylase activities of the NuRD complex were kept in check by Ikaros proteins, likely
providing a physical barrier through DNA binding, that limits access to the nucleosome and
its acetylated histone tails either by competition or by altering Mi-2β conformation and
enzymatic activity. At active lymphoid genes, reduction in Ikaros DNA binding increased
local access by Mi-2β, nucleosome remodeling and histone deacetylation and interfered with
the RNA polII transcription cycle and gene expression. In the absence of Ikaros, the related
family member Aiolos with similar DNA binding specificity still targeted the NuRD
complex to these locations and limited local chromatin access, albeit not to the extent of
both factors working together. Consistent with this model, more severe Ikaros-related
phenotypes are observed in mice with combined Ikaros and Aiolos null mutations or in
mouse and human with Ikaros dominant-negative mutations that interfere with activity of
both factors9,16,34.
Loss in Ikaros DNA binding allows more access to Mi-2β not only at lymphoid gene targets,
but also at transcriptionally poised genes involved in cell growth and metabolism. Gain of
Mi-2β at these sites, normally present within permissive or bivalent chromatin, appears to
promote the RNA polII transcription cycle and gene activation. Notably, a fraction of these
normally repressed genes were marked by occupancy with the PRC2 complex, and gain in
Mi-2β occupancy antagonized this chromatin modifier. Antagonistic interactions between
PICKLE, the plant homologue of Mi-2β, and the polycomb protein CURLY LEAF were
recently shown to control expression of stem cell and meristem genes in Arapidopsis35.
While these genes do not contain significant Ikaros or other lymphoid-specific binding
motifs they contain basic transcriptional motifs including binding sites for the CTCF
insulator. An interaction between Mi-2β–NuRD and the cohesin complex that also interacts
with CTCF was previously reported36,37, and was also detected in our Mi-2β–NuRD
complex purification from thymocytes. Functional interactions between the cohesin and the
basic transcription mediator complexes that enable communication between enhancer and
core promoters in embryonic stem cells were recently shown38. A potential role for Mi-2β in
regulating insulator function and possibly promoter-enhancer communication through
interactions with the cohesin-CTCF and cohesin-mediator complexes present other
mechanisms through which the NuRD complex participates in the induction of poised genes.
Change in the DNA binding activity of Ikaros family proteins present within the NuRD
complex, may be the mechanism through which activity of this complex and expression of
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functionally opposing genetic programs is modulated from the most primitive lymphoid
progenitor to the mature effector lymphocyte. Transcriptional and post-transcriptional events
that target Ikaros expression and activity39-42, are likely to provide complexity in the
regulation of the NuRD complex and may be key to successful transitions through the
proliferative and quiescent stages of lymphocyte differentiation.
Association of the Ikaros-NuRD complex with both transcriptionally active and poised
genes in thymocytes provides us with a snap shot of their dual potential as activators and
repressors of gene expression, which is likely dictated by the activity of neighboring factors.
For example, Ikaros has been perceived as a repressor of Cd4 gene expression in DN
thymocytes18, whereas our current studies indicate that it also serves to maintain Cd4 gene
expression in DP thymocytes. Ikaros association with the inactive Cd4 locus at the DN stage
may antagonize Mi-2β remodeling, thus promoting activity of negative regulators, such as
the PRC2 complex. Reduction in Ikaros DNA binding activity at the DN stage may increase
Mi-2β remodeling that antagonizes local repressors and activates the Cd4 gene. Reinstating
Ikaros DNA binding activity and the Ikaros-NuRD complex at the transcriptionally active
Cd4 locus in quiescent DP thymocytes bestows Ikaros a new role as a guardian of Cd4 gene
expression at this developmental stage. Reduction in Ikaros activity at this DP stage or
during subsequent transitions again increases Mi-2β chromatin remodeling activity, which at
this stage may antagonize the basal transcription machinery and thereby cause Cd4 gene
inactivation.
An uncontrolled gain-of-function of the NuRD complex in DP thymocytes brings about
disparate epigenetic effects that disrupt stage-specific activation and repression of genetic
programs required for normal differentiation. Targeting of chromatin modifying enzymes for
therapeutic intervention, especially histone deacetylases, is the focus in treating T cell
leukemias as well as debilitating immune disorders43,44. Understanding the roles played by
HDAC complexes in the epigenetic regulation of differentiation versus cell growth and
proliferation through their interactions with lineage-specific DNA binding factors and other
epigenetic regulators is important for our ability to manipulate cell fate choices and their
aberrant manifestations in an intelligent fashion.
METHODS
Animals
Ikaros null mice (ΔIk), Ikaros dominant negative (IkDN) and WT strains were bred and
housed under pathogen-free conditions as described14. Animal experiments were reviewed
and approved by the MGH Subcommittee on Research Animal Care (SRAC). Mice were
sacrificed at 3-5 weeks of age (for pre-leukemic: stage I-II) and >10 weeks (for leukemic:
stage III- upon Notch signaling activation). Staging of mutant thymi was determined by
phenotypic analysis of DP thymocytes as described16. Thymocytes were used for cellular,
gene expression and chromatin studies. Ikaros-Mi-2β-flag mice10,39 and CD2-Flag-Ikaros
transgenic mice were used for flag-tag protein purification from primary thymocytes as
described7.
Antibody reagents
Cocktails of home-produced monoclonal antibodies were used for Ikaros (4E9, Ik14), Mi–2β
(16G4, 2G8, 17H11) and Aiolos (9D10) ChIP with WT and ΔIk chromatin 7,17,18. For HEB,
the sc357 antibody from Santa Cruz was used. For RNA polII and histone modification
studies: anti-H3K4me3 (Abcam ab8580 or Millipore 07-473), anti-H3K4me2 (Millipore
07-030), anti-H3K4me1 (Abcam ab8895), anti-H3K9Ac-K14Ac (Millipore 06-599), anti-
H3K27me3 (Millipore 07-449), and anti-H3K36me3 (Abcam ab9050) and anti-RNA polII
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S5 (Abcam ab5131) were used for ChIP with WT and ΔIk chromatin. Phenotypic analysis
and sorting of DP thymocytes was performed by flow cytometry using FACSCanto (BD) or
MoFlo (Cytomation). The antibodies used in these studies were CD4-PE-Cy5.5 (or CD4-PE-
Cy7), CD8α-FITC, TCRβ-APC and CD5-PE, CD25-PE, HSA-PE, CD69PE, Thy1.2-PE,
CD62L-APC and CD44-APC as described16.
ChIP-Seq
ChIP was performed on DP-enriched thymocytes (1×107-1×108) isolated from 3-5 week old
WT and Ikaros null mice with 3-5 μg of antibodies to Ikaros, Mi–2β, Aiolos, HEB,
H3K4me3, H3K9Ac-K14Ac , H3K27me3, H3K36me3 and RNA polII S5. Sequencing
libraries were generated from 10-20 ng of ChIP or input DNA using either an Illumina kit or
a home-made kit using reagents from NEB. Prior to and after library amplification, target
enrichment in ChIPed DNA material was validated by candidate target approach as
previously described16,18. Sequencing was performed on a Genome Analyzer II (Illumina).
ChIP-Seq data analysis
Single-ended 32bp sequences were mapped to the mouse genome assembly mm9 using the
ELAND alignment tool in GApipeline accepting no more than two mismatches. Uniquely
aligned tags were selected, converted to bed files and after read normalization were analyzed
by the peak calling software MACS45 for robust and high resolution enrichment peak
predictions. The algorithm was applied, using a 2d sliding window across the genome to
find candidate peaks with significant tag enrichment according to Poisson distribution at a
default P-value of 10−05 with input control data (Supplementary Fig. 9). Biological
replicates for Ikaros and Mi-2β ChIP-Seq experiments were performed, verified by
comparing enriched peaks and then combined into a single dataset.
To detect differential regulation of Mi–2β and H3-modification enrichment between WT and
ΔIk chromatin, three steps were taken. First, peak calling with MACS was conducted
between input control and the WT or ΔIk sample, respectively. Second, direct comparison
between the WT and ΔIk sample was conducted with MACS. Third, peaks called in the
second step were filtered though the peak list from the first step based on binding site
overlap. For example, any peaks identified as up-regulated in ΔIk sample were also
significant when ΔIk was compared against its input control; any peaks identified as up-
regulated in WT were also present in the WT peak list deduced by comparing the WT
sample to its input control (Supplementary Fig. 9). To test if the difference in the number
of sequencing reads between two conditions (e.g. WT and ΔIk) affected the final differential
regulated peak list and to what extent, we used random sampling to draw equal number of
reads from each condition and run the above three step analyses. A very similar peak list in
terms of number of called peaks and peak locations was obtained using either method.
Binding site profiling and GO analysis
All of the genome-wide annotations and statistics of protein–DNA interaction patterns from
ChIP-seq data were performed with in-house scripts of the R and Perl programming
language. Binding sites were assigned to the nearest transcripts based on the distance from
gene Transcriptional Starting Site (TSS) to the peak summit of binding sites. Enriched DNA
motifs at Ikaros, Aiolos and Mi–2β sites were obtained using the HOMER (Hypergeometric
Optimization of Motif EnRichment) software (http://biowhat.ucsd.edu/homer/introduction/
programs.html). Genomic sequences 100-300 bp upstream or downstream of Ikaros or
Aiolos binding peaks were scrutinized to identify motifs present in these fragments on the
basis of their statistical enrichment. GO analysis of target genes was conducted using the
Functional Annotation Tool of the DAVID software.
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Hierarchical clustering
Genomic binding patterns from multiple ChIP-seq studies were deduced by Ward's
hierarchical clustering22 using the R statistical platform with hclust function. Specifically,
normalized tags located at significant binding sites called by MACS were counted for each
base position for each ChIP-seq experiment. Then the signal intensity pattern at these
position-indexed tag numbers was tested relative to other genomic features, such as TSS
sites and normalized ChIP-seq peaks from other factors. The tag numbers with positions
falling within 6 kb regions centered around each genomic feature were pulled out for
clustering. Numbers for each 6 kb region formed a row, and all rows were stacked together
to form a matrix as input for the hclust function in R after percentage conversion. This step
of percentage conversion is necessary for comparison of the signal intensities between two
conditions (e.g. WT and ΔIk) and captures the genomic location and pattern of the ChIP-Seq
signal simultaneously. Specifically for two-condition comparison, tag numbers in each row
were converted to percentage fraction relative to the total number of tags. To obtain a
combinatory pattern from multiple ChIP-seq studies, matrices from all ChIP-seqs were
juxtaposed into a larger matrix that was used as input for hierarchical clustering by the Ward
method.
Gene expression microarrays
DP thymocytes from WT, ΔIk and IkDN mice were obtained at different stages of
leukemogenesis (stage I, stage II, and stage III) as described16 and profiled for RNA
expression. A common signature of up- and down-regulated genes defined by both
chromatin and RNA expression changes across Ikaros mutant compared to WT DP
thymocytes was deduced. Comparative analysis of gene expression profiles from WT and
Ikaros mutant DP was performed by the Bioconductor limma package46. Likelihood of over-
representation of functional categories in the up- or down-regulated gene list relative to a
background of all array genes was calculated by Fishers’ exact test. Genes with an absolute
fold change in transcript level exceeding 1.5 and multiple test-adjusted P-value less than
0.05 were compared to the H3K36me3 changes occurring between WT and ΔIk chromatin at
P-value of 10−5. Gene expression datasets obtained from sorted thymocyte subsets (e.g,
DN1, DN2, DN3, pre-DP, blDP, smDP, CD4SP and CD8 SP) as described by47 were used
to generate a heatmap of gene expression during T cell development for the subset of genes
deregulated upon loss of Ikaros at the pre-leukemic state (stage I and II).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. NuRD complex composition in primary DP thymocytes
(a) NuRD complex components were isolated from primary resting thymocytes (r-thy) or
cycling T cells (cy-T cells) from mice transgenic for either Mi-2β-flag or flag-Ikaros using
heparin sepharose and anti-Flag immunoaffinity columns as previously described7. The
composition of Mi-2β-Flag and Flag-Ikaros purified complexes was visualized by colloidal
blue staining of gradient acrylamide gels. A mock purification of non-transgenic thymocytes
is provided as specificity control (c). Data shown is representative of more than two
independent complex purifications performed from Mi-2β-flag or flag-Ikaros expressing
cells. (b) Immunoblot analysis of Mi–2β-flag and flag-Ikaros based complexes shows strong
enrichment for NuRD complex components (Mi-2β, α, MTA1, 2, HDAC1, 2, Rbp46, 48)5
and Ikaros family members (i.e. Ikaros isoforms Ik-1 and Ik-2 and Aiolos) relative to
unfractionated nuclear extract (nuc). 1x-indicates loading of ~10ng of purified complex
compared to 1.5-2 micrograms of nuclear extract. Analysis of a mock purification (c) from
non-transgenic thymocytes was performed in parallel to the Mi–2β-flag purification. Full
protein characterization is described in Supplementary Table 1.
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Figure 2. Genome-wide mapping of the Ikaros-NuRD complex in permissive chromatin and
transcriptionally active genes
Genome-wide analyses of Ikaros and Mi-2β enrichment peaks obtained from ChIP-Seq
replicates on the two factors identifying unique gene targets. (a) Highly significant overlap
between Ikaros and Mi-2β gene targets (GT) (P-value = 10−320). (b) Ward's hierarchical
clustering centered on Ikaros (Ik) binding sites and further analyzed within +/− 3 kb window
for occupancy by Mi-2β, H3K4me3 (K4me3), H3K4me2 (K4me2), H3K4me1 (K4me1),
H3K9Ac (K9Ac), RNA polII (polII) and H3K27me3 (K27me3). All Ikaros peaks were
included in the analysis. Ikaros binding sites are grouped by promoter-proximal (<3 kb from
the transcription start site, TSS, top) or promoter-distal (>=3 kb, bottom) locations. (c) Pie-
chart distribution of Ikaros and Mi-2β sites at various genomic locations. (d) Expression
analysis of gene subsets with and without Ikaros and or Mi-2β enrichment peaks in WT DP
thymocytes. The bottom and top of each Whisker box plot represent the 25th and 75th
percentile and the internal band the 50th percentile (median) in the group. P-values for the
difference in expression between subsets and the all-gene group are shown. (e) Ikaros,
Mi-2β, H3K4me3, H3K9Ac and RNA polII distribution relative to TSS. Biological
replicates for Ikaros and Mi-2β ChIP-Seq experiments with good overlap (>50%) were
pooled and used for peak analysis and data presentation. Enrichment peaks for H3
modifications in WT chromatin (i.e. H3K4m3, me2, me1, H3K9Ac, RNA polII or
H3K27me3) were deduced from one ChIP-Seq experiment as they displayed expected
correlation with each other and with regulatory domain distribution.
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Figure 3. Loss of Ikaros causes a profound gain in Mi-2β chromatin enrichment, remodeling and
histone deacetylation
(a) Ward's hierarchical clustering of Mi-2β-centered binding sites analyzed as in Fig. 2 for
Ikaros, Aiolos, RNA polII, and H3 modifications in WT and Ikaros null (ΔIk) chromatin. All
Mi-2β enrichment peaks obtained in Ikaros null chromatin were used in this analysis. (b)
Increase in Mi-2β in ΔIk chromatin at non-Ikaros and Ikaros gene targets. (c) Immunoblot
analysis of Mi-2β protein in WT and ΔIk total thymocyte extracts. Expression of Notch1 and
Ikaros proteins are shown as controls. (d) Progressive narrowing of the Mi-2β distribution
pattern over its enrichment peak in WT and ΔIk chromatin correlates with loss of co-
occupancy by Ikaros or Aiolos. (e) Cumulative analysis of H3 modifications and RNA polII
changes relative to the center of Mi-2β peaks in WT (black) and ΔIk (red) chromatin.
Biological replicates for transcription factors were performed as described in Figure 2. Two
biological replicates of Ikaros null pre-leukemic samples (−1, −2) were used for ChIP-Seq
experiments and enrichment peak analysis for H3K9Ac, H3K4me3 and H3K27me3.
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Figure 4. Targeting of the Mi-2β-NuRD complex to a lymphoid-specific gene network
(a) Identification of Ikaros-related (m1-m5) and non-related motifs in the vicinity of Ikaros
sites at promoter-proximal (top) and distal (bottom) locations in WT chromatin and log10
(P-value) for motif occurrence. (b) Context-specific frequencies of factor motifs in the
vicinity (+/− 300 bp) of Ikaros (black) and Aiolos (red) enrichment peaks in WT and ΔIk
chromatin. The distribution and moving average of motif frequencies within a 15bp window
is shown. (c) Ward's hierarchical clustering of Ikaros, HEB and H3K4me3, me2 and me1
modifications at promoter proximal and distal locations as described in Fig. 2. All Ikaros
peaks obtained in WT chromatin are included in this analysis.
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Figure 5. GO pathway analysis of Mi-2β gene targets
(a) Context-specific frequencies of transcription factor motifs (Ikaros motif 1, E2A, Runx,
CTCF, E-box, GC) identified in the vicinity (+/− 300 bp) of Mi-2β peaks that were (black)
or not (red) associated with Ikaros or Aiolos peaks in WT and ΔIk chromatin as described in
Fig. 4c. (b) Gene ontology of Mi-2β, Ikaros and Aiolos gene targets (+Ik or Aio) or Mi-2β
alone (–Ik or Aio) gene targets established in WT and ΔIk chromatin. The significance in
pathway enrichment is shown as - log10(P-value).
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Figure 6. Loss of Ikaros-mediated effects on gene expression reveals two functionally opposing
mechanisms of NuRD-dependent transcriptional regulation
(a) A pre-leukemic signature is defined in Ikaros-deficient DP thymocytes by loss (Down)
or gain (Up) in transcriptional elongation (H3K36me3) and RNA expression. TSS-centered
distribution of H3 modifications in down- and up-regulated genes in wild-type (wt) and
Ikaros null (ΔIk-1 and ΔIk-2) DP thymocytes ordered from the most to the least significant
change in expression. RNA expression of these genes at the pre-leukemic and leukemic
stages (SI-III) as well as during normal T cell differentiation (DN1-4, DP, CD4 and CD8) is
shown by heat maps. (b) Cumulative effect on H3K9Ac, RNA polII and H3K27me3 at the
TSS of down- and up-regulated genes. (c) Representative examples of down- and up-
regulated genes shown by IGV browser display of Ikaros, Aiolos, Mi-2β and HEB peaks
identified using the MACS algorithm with appropriate input controls45. Differential
enrichment for Mi-2β, RNA polII and H3 modification peaks between WT vs. Ikaros null
chromatin was also obtained using MACS. In comparative analyses (wt vs. ΔIk or ΔIk vs.
wt), the presence of reads indicates a signal increase, whereas the absence indicates a lack of
signal change between the two conditions.
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Table 1
Chromatin status of Ikaros, Aiolos or Mi–2β gene targets
H3K4me3 H3K9Ac H3K27me3 H3K36me3 RNApIIS5
Ikaros WT 87% 83% 39% 70% 61%
Mi−2β WT 87% 84% 40% 73% 66%
Aiolos IkΔ 88% 83% 43% 68% 56%
Mi−2b IkΔ 84% 80% 43% 67% 55%
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